PRJNA682853
Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients
Peritoneal dialysis (PD) is a renal replacement therapy for end-stage renal disease. Gut microbiota-derived uremic solutes, indoxyl sulfate (IS), p-cresyl sulfate (PCS), and trimethylamine-N-oxide (TMAO) accumulate in PD patients. We investigated the gut microbiota and their influence on uremic toxins in PD patients and healthy controls (HCs).